Arimidex (anastrozole)
Arimidex™ (anastrozole), an oral aromatase inhibitor (AI), is an endocrine (hormonal) therapy for the treatment of hormone-sensitive breast cancer in postmenopausal women. ARIMIDEX was first launched in 1995 for the treatment of advanced disease and the first approvals for early breast cancer treatment followed in 2002.
Did you know?
AstraZeneca has a range of product specific and disease area websites for international healthcare professionals and patients. Links to this information can be found below.
Links to country-specific websites can be found using the AstraZeneca websites list.
If you still have a question regarding our drug portfolio you can Contact us.
